Emami Q4 results: Net profit declines 12% to ₹143 crore, revenue falls 4%

The company had posted a net profit of ₹162.17 crore in the year-ago period.

Revenue from operations during the January-March period fell 3.94% to ₹925.1 crore, compared to ₹963.05 crore a year ago, the company said in a regulatory filing.

Total expenses of the company also slipped 0.70% to ₹738.4 crore against ₹743.61 crore in the same period of the preceding fiscal.

The company reported a 2.51% decline in its EBITDA (earnings before interest, taxes, depreciation, and amortisation) to ₹232 crore for the quarter from ₹266 crore in Q4 FY25. The EBITDA margin was at 25.09% vs 27.59%.

The March quarter was affected by unfavourable seasonal conditions impacting the summer portfolio, along with geopolitical disruptions in West Asia.

Despite the temporary external headwinds, the underlying business fundamentals of the company remained resilient and well-positioned for long-term growth.

For FY26, revenue stood at ₹3,780 crore. gross margin expanded by 130 basis points (bps) to 69.9%, EBITDA stood at ₹964 crore and net profit at ₹775 crore.

Harsha V Agarwal, Vice Chairman and Managing Director, Emami, said, "Q4FY26 was impacted by temporary external headwinds, including unfavourable seasonal conditions affecting the summer portfolio and geopolitical disruptions in West Asia, which weighed on overall business performance during the quarter. Despite these challenges, the resilience of our core domestic business remained evident, with the non-summer portfolio delivering healthy 11% growth."

"In the current financial year, we are strengthening our future growth portfolio through investments in Axiom Ayurveda and IncNut Digital, aligned with evolving consumer preferences and emerging market opportunities," he added.